SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-154186
Filing Date
2023-05-25
Accepted
2023-05-25 16:00:33
Documents
12
Period of Report
2023-05-25
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d645049d8k.htm   iXBRL 8-K 22219
  Complete submission text file 0001193125-23-154186.txt   146886

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eq-20230525.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20230525_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20230525_pre.xml EX-101.PRE 11708
6 EXTRACTED XBRL INSTANCE DOCUMENT d645049d8k_htm.xml XML 3461
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 23960341
SIC: 2834 Pharmaceutical Preparations